- Home
- App Analytics
- Micromedex Drug Interactions
- Micromedex Drug Interactions Vs. UpToDate Lexidrug
Micromedex Drug Interactions vs UpToDate Lexidrug Usage & Stats
The support of this app will be discontinued on Feb 20, 2025. Visit the App Store to download the new Micromedex mobile app
https://apps.apple.com/app/merative/id6471286555
Micromedex Drug Interactions app is free to subscribers of Merative Micromedex Drug Interactions online.
With Micromedex Drug Interactions, clinicians can check a patient’s entire medication list simultaneously for potentially harmful interactions and view severity ratings that range from contraindicated to minor. This app provides insight into:
• Why the drugs in question interact.
• How the results of those interactions will present in the patient.
• Recommendations for monitoring patient outcomes.
Micromedex Drug Interactions is a reliable resource for on-the-go access to the industry’s most trusted clinical reference information, providing users with more informed treatment decisions at the point of care. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
Micromedex Drug Interactions customers simply follow these instructions to obtain a password:
1. Login to Merative Micromedex through your subscribing facility.
2. Click “Mobile Application Access” near the top of the application.
3. Refer to the detailed downloading instructions, which include your password for activating the application at no charge.
Not sure if your institution subscribes to Merative Micromedex Drug Interact via the internet? Check with your Director of Pharmacy, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If you cannot locate the “Mobile Applicaiton Access” link or are having problems with your password, please contact support at https://merative.my.site.com/mysupport/s/micromedex-support-request
- Apple App Store
- Free
- Medical
Store Rank
- -
Any Drug Question. Anytime. Anywhere
UpToDate® Lexidrug™ drug reference on mobile apps are unique in the industry for being as extensive as our online drug reference offerings. No content is abridged. Users can view more than 20 databases, featuring timely, in-depth information on drugs, natural products, interactions, medical calculations and more, whether in the hospital or on-the-go.
Provides unique features other drug information apps don’t have, like a pharmacogenomics database, IV compatibility data, drug shortage information, patient education leaflets, and the ability to reorder databases and monograph fields to customize display.
Content is stored directly on the device – clinicians can quickly answer questions even if there is a weak mobile signal or no internet connection. Used and trusted by pharmacists, physicians, nurses, advanced practice nurses, dentists, and students.
New individual users will receive a one month free trial to UpToDate Lexidrug Hospital Pharmacist Package. At the end of the free trial, users will automatically be billed $29.99 per month via their iTunes Account for continuing access. To avoid being charged, users must cancel their free trial at least 24 hours before the end of the trial period. Users can manage settings, cancel subscriptions, or turn off auto-renewal anytime during the subscription period via iTunes Account Settings.
Any unused portion of a free trial period, if offered, will be forfeited when the user purchases a subscription to that publication, where applicable.
- Apple App Store
- Free
- Medical
Store Rank
- -
Micromedex Drug Interactions vs. UpToDate Lexidrug ranking comparison
Compare Micromedex Drug Interactions ranking trend in the past 28 days vs. UpToDate Lexidrug
Rank
No Data Available
Micromedex Drug Interactions vs. UpToDate Lexidrug ranking by country comparison
Compare Micromedex Drug Interactions ranking trend in the past 28 days vs. UpToDate Lexidrug
All categories
No Data Available
Medical
Compare to any site with our free trial
Micromedex Drug Interactions VS.
UpToDate Lexidrug
December 25, 2024